Signaling pathways
-
BA4732 RVX-297Summary: RVX-297 is a potent, orally active, selective inhibitor. - BA4733 GSK4028Summary: GSK4028 is an enantiomer-negative control for GSK4027, a chemical probe for the PCAF/GCN5 bromodomain.
- BA4735 LP99Summary: LP99, an epigenetic probe, is a potent and selective inhibitor of bromodeoxyribose.
- BA4736 I-BET567Summary: I-BET567 is a potent, orally active candidate inhibitor.
- BA4737 BETd-246Summary: BETd-246 is a second-generation, technology-based, inhibitor of...
- BA4738 Y06036Summary: Y06036 is a potent and selective inhibitor that binds to the bromo structural domain.
- BA4739 iBRD4-BD1Summary: iBRD4-BD1 is a selective BRD4 bromodomain inhibitor.
- BA4740 BET-IN-19Summary: BET-IN-19 is an inhibitor.
- BA4741 GSK1379725ASummary: GSK1379725A is a selective ligand.
- BA4742 GSK852Summary: GSK852 is a very potent and selective inhibitor of BD2.